All In MedTech

Device Trial Radar · NCT07473947

Performance and Safety Follow-up of Bioabsorbable Headless Inion CompressOnTM Screws in the Fixation of Bone Fractures in Ankle, Knee and Elbow of Pediatric and Adolescent Patients

Last checked: Nov 19, 2026Latest source record: Jun 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

May 29, 2026

Primary completion

Feb 2032

Study completion Dec 2032

Sponsor

Lead sponsor
Inion OyNot on our public-company list
Sponsor type
Industry
First posted
Mar 16, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study in question is a post market clinical follow up (PMCF) study to follow up the safety and performance of bioabsorbable headless compression screw Inion CompressOn in fracture fixation of the ankle, knee and elbow of pediatric and adolescent patients. The study aims to recruit 80 patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Lighthouse Hospital at Turku University Hospital (TYKS) in Finland. The main focus of the study in terms of performance is to follow up the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

Conditions

  • Ankle Fractures
  • Knee Fractures
  • Elbow Fractures

Interventions

  • Fracture fixation operationDevice

    Fracture fixation operation in using bioabsorbable headless Inion CompressOn Screw/s according to instructions for use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Bone healing (ossification) of the fracture line(s)Time frame: Change from operation to 4 years
  2. Occurrence of device-related adverse eventsTime frame: During 4-year follow-up
  3. Occurrence of revision surgeriesTime frame: During 4-year follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Turku University Hospital/Lighthouse hospital

    Turku, Finland · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.